| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Cencora, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$206.60 |
| 52 Week High | US$227.40 |
| 52 Week Low | US$152.06 |
| Beta | 0.46 |
| 1 Month Change | -8.10% |
| 3 Month Change | -5.49% |
| 1 Year Change | 36.57% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 29.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| ABC | AT Healthcare | AT Market | |
|---|---|---|---|
| 7D | -7.9% | 2.5% | 1.3% |
| 1Y | 36.6% | -4.7% | 5.1% |
Return vs Industry: ABC exceeded the Austrian Healthcare industry which returned -4.7% over the past year.
Return vs Market: ABC exceeded the Austrian Market which returned 5.1% over the past year.
Price Volatility
| ABC volatility | |
|---|---|
| ABC Average Weekly Movement | 2.6% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in AT Market | 5.1% |
| 10% least volatile stocks in AT Market | 1.7% |
Stable Share Price: ABC has not had significant price volatility in the past 3 months.
Volatility Over Time: ABC's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 44,000 | Steve Collis | www.cencora.com |
Cencora, Inc. sources and distributes pharmaceutical products. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
Cencora, Inc. Fundamentals Summary
| ABC fundamental statistics | |
|---|---|
| Market cap | €41.49b |
| Earnings (TTM) | €1.72b |
| Revenue (TTM) | €256.87b |
24.1x
P/E Ratio0.2x
P/S RatioIs ABC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABC income statement (TTM) | |
|---|---|
| Revenue | US$276.54b |
| Cost of Revenue | US$267.14b |
| Gross Profit | US$9.40b |
| Other Expenses | US$7.55b |
| Earnings | US$1.85b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.29 |
| Gross Margin | 3.40% |
| Net Profit Margin | 0.67% |
| Debt/Equity Ratio | 427.8% |
How did ABC perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield22%
Payout RatioDoes ABC pay a reliable dividends?
See ABC dividend history and benchmarks| Cencora dividend dates | |
|---|---|
| Ex Dividend Date | May 09 2024 |
| Dividend Pay Date | May 24 2024 |
| Days until Ex dividend | 3 days |
| Days until Dividend pay date | 18 days |
Does ABC pay a reliable dividends?
See ABC dividend history and benchmarks